guidelines:
  1: R-ISS_guideline.v1
test_cases:
- id: ISS I
  input:
    1:
      gt0003|Serum β2 microglobulin: local::at0035|<3.5 mg/L|
      gt0004|Serum albumin: local::at0039|≥3.5 g/dL|
      gt0005|CA by iFISH: local::at0040|Standard risk|
      gt0006|LDH: local::at0042|Normal (< upper limit of normal)|
  expected_output:
    1:
      gt0009|R-ISS Stage: local::at0029|R-ISS Stage I|
      gt0008|ISS stage: local::at0032|ISS I|
      gt0018|Median progression-free survival: 66 months median progression-free survival
- id: ISS II case 1
  input:
    1:
      gt0003|Serum β2 microglobulin: local::at0035|<3.5 mg/L|
      gt0004|Serum albumin: local::at0038|<3.5 g/dL|
      gt0005|CA by iFISH: local::at0040|Standard risk|
      gt0006|LDH: local::at0042|Normal (< upper limit of normal)|
  expected_output:
    1:
      gt0009|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0008|ISS stage: local::at0033|ISS II|
      gt0018|Median progression-free survival: 42 months median progression-free survival
- id: ISS II case 2
  input:
    1:
      gt0003|Serum β2 microglobulin: local::at0036|3.5-5.4 mg/L|
      gt0004|Serum albumin: local::at0039|≥3.5 g/dL|
      gt0005|CA by iFISH: local::at0040|Standard risk|
      gt0006|LDH: local::at0042|Normal (< upper limit of normal)|
  expected_output:
    1:
      gt0009|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0008|ISS stage: local::at0033|ISS II|
      gt0018|Median progression-free survival: 42 months median progression-free survival
- id: ISS II case 3
  input:
    1:
      gt0003|Serum β2 microglobulin: local::at0036|3.5-5.4 mg/L|
      gt0004|Serum albumin: local::at0038|<3.5 g/dL|
      gt0005|CA by iFISH: local::at0040|Standard risk|
      gt0006|LDH: local::at0042|Normal (< upper limit of normal)|
  expected_output:
    1:
      gt0009|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0008|ISS stage: local::at0033|ISS II|
      gt0018|Median progression-free survival: 42 months median progression-free survival
- id: ISS III case 1
  input:
    1:
      gt0003|Serum β2 microglobulin: local::at0037|>5.4 mg/L|
      gt0004|Serum albumin: local::at0039|≥3.5 g/dL|
      gt0005|CA by iFISH: local::at0040|Standard risk|
      gt0006|LDH: local::at0042|Normal (< upper limit of normal)|
  expected_output:
    1:
      gt0009|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0008|ISS stage: local::at0034|ISS III|
      gt0018|Median progression-free survival: 42 months median progression-free survival
- id: ISS III case 2
  input:
    1:
      gt0003|Serum β2 microglobulin: local::at0037|>5.4 mg/L|
      gt0004|Serum albumin: local::at0038|<3.5 g/dL|
      gt0005|CA by iFISH: local::at0040|Standard risk|
      gt0006|LDH: local::at0042|Normal (< upper limit of normal)|
  expected_output:
    1:
      gt0009|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0008|ISS stage: local::at0034|ISS III|
      gt0018|Median progression-free survival: 42 months median progression-free survival
- id: R-ISS Stage III
  input:
    1:
      gt0003|Serum β2 microglobulin: local::at0037|>5.4 mg/L|
      gt0004|Serum albumin: local::at0038|<3.5 g/dL|
      gt0005|CA by iFISH: local::at0040|Standard risk|
      gt0006|LDH: local::at0043|High (> upper limit of normal)|
  expected_output:
    1:
      gt0009|R-ISS Stage: local::at0031|R-ISS Stage III|
      gt0008|ISS stage: local::at0034|ISS III|
      gt0018|Median progression-free survival: 29 months median progression-free survival
- id: R-ISS Stage II
  input:
    1:
      gt0003|Serum β2 microglobulin: local::at0035|<3.5 mg/L|
      gt0004|Serum albumin: local::at0039|≥3.5 g/dL|
      gt0005|CA by iFISH: local::at0040|Standard risk|
      gt0006|LDH: local::at0043|High (> upper limit of normal)|
  expected_output:
    1:
      gt0009|R-ISS Stage: local::at0030|R-ISS Stage II|
      gt0008|ISS stage: local::at0032|ISS I|
      gt0018|Median progression-free survival: 42 months median progression-free survival
